| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Serina Therapeutics, Inc. (SER) has 9 insiders with recent SEC Form 4 filings, including 19 buys and 0 sells. SER is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.33M | $6.03M | - | |
| CEO | 230.1K | $416.5K | - | |
| Dir | 92.0K | $166.5K | - | |
| VP | 85.6K | $154.9K | - | |
| Dir | 10.1K | $18.3K | +10.1K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Mintz Steven | Director | Buy | 6,000 | $6.47 | $38,814.00 | +52.4% | -23.0% | -16.0% | |
| Aug 20, 2024 | Bailey Gregory | Director | Buy | 1,776 | $8.25 | $14,652.00 | +3.9% | -39.4% | -37.0% | |
| Aug 19, 2024 | Bailey Gregory | Director | Buy | 19,200 | $7.30 | $140,116.48 | +19.4% | -38.2% | -38.1% | |
| Aug 15, 2024 | Mintz Steven | Director | Buy | 8,943 | $6.59 | $58,928.11 | +38.4% | -24.9% | -18.9% | |
| Aug 14, 2024 | Bailey Gregory | Director | Buy | 6,400 | $7.07 | $45,228.16 | +31.7% | -24.1% | -19.6% | |
| Jun 25, 2024 | Mintz Steven | Director | Buy | 7,600 | $9.33 | $70,900.00 | +65.4% | +2.6% | -29.6% | |
| May 30, 2024 | Bailey Gregory | Director | Buy | 6,378 | $9.50 | $60,591.00 | +22.1% | -17.4% | -36.8% | |
| May 28, 2024 | Bailey Gregory | Director | Buy | 9,019 | $9.50 | $85,680.50 | +187.5% | -16.6% | -40.2% | |
| May 23, 2024 | Bailey Gregory | Director | Buy | 3,287 | $9.50 | $31,226.50 | +83.0% | -13.7% | -38.4% | |
| May 21, 2024 | Bailey Gregory | Director | Buy | 1,422 | $9.50 | $13,509.00 | +1,422% | -18.1% | -45.2% |